← Back to Conditions

Molybdenum cofactor deficiency complementation group A

disorder
SNOMED 1003367004CUI C1854988

Overview

Molybdenum cofactor deficiency complementation group A is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Abnormal muscle tone
HP:0003808
Absent urinary urothione
HP:0003606
Aldehyde oxidase deficiency
HP:0002932
Arc de cercle
HP:0002179
Axonal loss
HP:0003447
Big cheeks
HP:0000293
Decreased size of cranium
HP:0000252
Decreased urinary sulfate
HP:0003359
Decreased urinary urate
HP:0011935
Degeneration of cerebrum
HP:0002059
Dilated cerebral ventricle
HP:0002119
Elevated urinary S-sulfocysteine level
HP:0034744
Epilepsy
HP:0001250
Excess astrocytes in brain
HP:0002171
Feeding difficulties in infancy
HP:0008872
Frontal protuberance
HP:0002007
Hypoplasia of corpus callosum
HP:0002079
Increased distance between eyes
HP:0000316
Increased length of philtrum
HP:0000343
Increased size of skull
HP:0000256
Increased urinary hypoxanthine level
HP:0011814
Increased urinary sulfite level
HP:0011942
Increased urinary taurine
HP:0003166
Increased urinary thiosulfate
HP:0011943
Involuntary, rapid, rhythmic eye movements
HP:0000639
Lens dislocation
HP:0001083
Lens luxation
HP:0012019
Low blood uric acid levels
HP:0003537
Low intelligence
HP:0001249
Molybdenum cofactor deficiency
HP:0003570

Quick Facts

SNOMED CT
1003367004
UMLS CUI
C1854988
Fully Specified Name
Molybdenum cofactor deficiency complementation group A (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
30
Known Treatments
2
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.